These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 3071066)

  • 1. Blood lactate behavior after glucose load in diabetes mellitus.
    Prando R; Cheli V; Buzzo P; Melga P; Ansaldi E; Accoto S
    Acta Diabetol Lat; 1988; 25(3):247-56. PubMed ID: 3071066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucose tolerance and insulin response in parents of patients with insulin-dependent and juvenile-onset non-insulin-dependent diabetes mellitus.
    Matsuda A; Kuzuya T
    Diabetes Res Clin Pract; 1992 Apr; 16(1):37-46. PubMed ID: 1576930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diurnal variation of blood ketone bodies in insulin-dependent diabetes mellitus and noninsulin-dependent diabetes mellitus patients: the relationship to serum C-peptide immunoreactivity and free insulin.
    Ubukata E
    Ann Nutr Metab; 1990; 34(6):333-42. PubMed ID: 2076025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A study of serum free C-peptide responses to oral glucose load in diabetic patients: with special reference to types of diabetes and methods of treatment.
    Hsieh SD; Akanuma Y; Takaku F
    Tohoku J Exp Med; 1984 Mar; 142(3):249-60. PubMed ID: 6374968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma alanine and lactate concentrations following glucose ingestion in normal and NIDDM subjects.
    Donatelli M; Russo V; Bucalo ML; Scarpinato A; Veronelli A; Craveri A
    Diabetes Res; 1992; 20(4):121-6. PubMed ID: 1345005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of ambient blood glucose level and degree of obesity on basal serum C-peptide level and the C-peptide response to glucose and glucagon in non-insulin-dependent diabetes mellitus.
    Park SW; Ihm SH; Yoo HJ; Park JY; Lee KU
    Diabetes Res Clin Pract; 1997 Sep; 37(3):165-71. PubMed ID: 9306037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lactate generation following glucose ingestion: relation to obesity, carbohydrate tolerance and insulin sensitivity.
    Lovejoy J; Mellen B; Digirolamo M
    Int J Obes; 1990 Oct; 14(10):843-55. PubMed ID: 2269580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The glucose dependent insulinotropic polypeptide response to oral glucose and mixed meals is increased in patients with type 2 (non-insulin-dependent) diabetes mellitus.
    Jones IR; Owens DR; Luzio S; Williams S; Hayes TM
    Diabetologia; 1989 Sep; 32(9):668-77. PubMed ID: 2676668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin inhibition of overnight glucose production and gluconeogenesis from lactate in NIDDM.
    Yki-Järvinen H; Helve E; Sane T; Nurjhan N; Taskinen MR
    Am J Physiol; 1989 Jun; 256(6 Pt 1):E732-9. PubMed ID: 2660587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Islet amyloid polypeptide (IAPP) secretion from islet cells and its plasma concentration in patients with non-insulin-dependent diabetes mellitus.
    Hanabusa T; Kubo K; Oki C; Nakano Y; Okai K; Sanke T; Nanjo K
    Diabetes Res Clin Pract; 1992 Jan; 15(1):89-96. PubMed ID: 1541240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin response to oral glucose load is consistently decreased in established non-insulin-dependent diabetes mellitus: the usefulness of decreased early insulin response as a predictor of non-insulin-dependent diabetes mellitus.
    Kosaka K; Kuzuya T; Hagura R; Yoshinaga H
    Diabet Med; 1996 Sep; 13(9 Suppl 6):S109-19. PubMed ID: 8894494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucose tolerance and insulin response to glucose load before and after enzyme inducing therapy in subjects with glucose intolerance and patients with NIDDM having hyperinsulinemia or relative insulin deficiency.
    Sotaniemi EA; Karvonen I
    Diabetes Res; 1989 Jul; 11(3):131-9. PubMed ID: 2697484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of insulin release and relative peripheral resistance with use of the oral glucose tolerance test: a study in subjects with normoglycaemia, glucose intolerance and non-insulin-dependent diabetes mellitus.
    Cederholm J; Wibell L
    Scand J Clin Lab Invest; 1985 Dec; 45(8):741-51. PubMed ID: 3909372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of metformin action in obese and lean noninsulin-dependent diabetic subjects.
    DeFronzo RA; Barzilai N; Simonson DC
    J Clin Endocrinol Metab; 1991 Dec; 73(6):1294-301. PubMed ID: 1955512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prevalence of low insulin responders to oral glucose load among groups with various patterns of family history of diabetes.
    Matsuda A; Kuzuya T
    Diabet Med; 1996 Sep; 13(9 Suppl 6):S59-62. PubMed ID: 8894484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma insulin, C-peptide, and proinsulin concentrations in obese and nonobese individuals with varying degrees of glucose tolerance.
    Reaven GM; Chen YD; Hollenbeck CB; Sheu WH; Ostrega D; Polonsky KS
    J Clin Endocrinol Metab; 1993 Jan; 76(1):44-8. PubMed ID: 8421101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved postprandial metabolic control after subcutaneous injection of a short-acting insulin analog in IDDM of short duration with residual pancreatic beta-cell function.
    Pampanelli S; Torlone E; Ialli C; Del Sindaco P; Ciofetta M; Lepore M; Bartocci L; Brunetti P; Bolli GB
    Diabetes Care; 1995 Nov; 18(11):1452-9. PubMed ID: 8722069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterogeneous relationship of early insulin response and fasting insulin level with development of non-insulin-dependent diabetes mellitus in non-diabetic Japanese subjects with or without obesity.
    Yoshinaga H; Kosaka K
    Diabetes Res Clin Pract; 1999 May; 44(2):129-36. PubMed ID: 10414932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antidiabetogenic effect of glucagon-like peptide-1 (7-36)amide in normal subjects and patients with diabetes mellitus.
    Gutniak M; Orskov C; Holst JJ; Ahrén B; Efendic S
    N Engl J Med; 1992 May; 326(20):1316-22. PubMed ID: 1348845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defective amplification of the late phase insulin response to glucose by GIP in obese Type II diabetic patients.
    Vilsbøll T; Krarup T; Madsbad S; Holst JJ
    Diabetologia; 2002 Aug; 45(8):1111-9. PubMed ID: 12189441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.